Non-Current Assets
Other Non-Current Assets
Amgen Other Non-Current Assets increased by 0.8% to $12.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $11.39B to $12.76B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 17.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Changes often reflect strategic shifts in long-term investments or changes in tax accounting.
Detailed definition
Long-term assets that do not fall into standard categories like property or intangibles, often including long-term inves...
Peer comparison
Standard line item; varies significantly based on specific corporate accounting policies.
Metric ID:
other_non_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.78B | $6.31B | $6.52B | $6.07B | $6.02B | $6.34B | $5.9B | $7.63B | $7.19B | $7.84B | $9.61B | $9.01B | $8.82B | $10.38B | $9.93B | $11.39B | $11.02B | $13.22B | $12.66B | $12.76B |
| QoQ Change | — | +9.0% | +3.4% | -7.0% | -0.8% | +5.3% | -6.9% | +29.4% | -5.8% | +8.9% | +22.7% | -6.3% | -2.1% | +17.8% | -4.4% | +14.7% | -3.2% | +20.0% | -4.2% | +0.8% |
| YoY Change | — | — | — | — | +4.1% | +0.5% | -9.6% | +25.7% | +19.4% | +23.6% | +62.9% | +18.0% | +22.6% | +32.5% | +3.3% | +26.4% | +25.0% | +27.3% | +27.5% | +12.0% |
Range$5.78B – $13.22B
CAGR+18.1%
Avg YoY Growth+20.1%
Median YoY Growth+23.1%
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Amgen's other non-current assets?
- Amgen (AMGN) reported other non-current assets of $12.76B in Q1 2026.
- How has Amgen's other non-current assets changed year-over-year?
- Amgen's other non-current assets increased by 12.0% year-over-year, from $11.39B to $12.76B.
- What is the long-term trend for Amgen's other non-current assets?
- Over 5 years (2020 to 2025), Amgen's other non-current assets has grown at a 17.6% compound annual growth rate (CAGR), from $5.64B to $12.66B.
- What does other non-current assets mean?
- Miscellaneous long-term assets that are not property, equipment, or intangible assets.